第十一批国采：九典制药、力强药业、泰德制药拟中选洛索洛芬贴剂/洛索洛芬贴膏剂

Core Viewpoint - The eleventh batch of national procurement results indicates that four companies are competing for the qualification to supply the transdermal patch/ointment of Loxoprofen, with three companies, including Jiutian Pharmaceutical, Lijiang Pharmaceutical, and Beijing Tide Pharmaceutical, winning the bid, while the original manufacturer, LEAD CHEMICAL CO., LTD., lost the bid [1] Group 1: Companies Involved - Jiutian Pharmaceutical, through its subsidiary Hunan Puda Medical Technology Co., Ltd., is one of the winning bidders for the Loxoprofen transdermal patch/ointment [1] - Harbin Lijiang Pharmaceutical Co., Ltd. is also among the companies that secured the bid for the Loxoprofen product [1] - Beijing Tide Pharmaceutical Co., Ltd. is the third company that has been awarded the qualification to supply the Loxoprofen transdermal patch/ointment [1] Group 2: Market Insights - The sales revenue of Loxoprofen transdermal patch/ointment in domestic public hospitals is expected to exceed 1 billion in 2024 [1] - Jiutian Pharmaceutical holds a significant market share in the domestic market for Loxoprofen products [1]